Inhibition of STAT3 expression and signaling in resveratrol-differentiated medulloblastoma cells

Neoplasia

Volumn 10, Issue 7, 2008, Pages 736-744

  Yu, Li Jun ^a   Wu, Mo Li ^a   Li, Hong ^a   Chen, Xiao Yan ^a   Wang, Qian ^a   Sun, Yuan ^a   Kong, Qing You ^a   Liu, Jia ^a  

^a DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; CYCLOOXYGENASE 2; LEUKEMIA INHIBITORY FACTOR; N BENZYL 2 CYANO 3 (3,4 DIHYDROXYPHENYL)ACRYLAMIDE; PROTEIN BCL 2; RESVERATROL; STAT3 PROTEIN; SURVIVIN;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CANCER GENETICS; CANCER INHIBITION; CELL CULTURE; CHEMOSENSITIVITY; CONTROLLED STUDY; DOWNSTREAM PROCESSING; FLOW CYTOMETRY; GENE EXPRESSION REGULATION; GENE REPRESSION; GENE SILENCING; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; MEDULLOBLASTOMA; NERVE CELL DIFFERENTIATION; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PROTEIN SECRETION; SIGNAL TRANSDUCTION; TUMOR CELL LINE; TUMOR DIFFERENTIATION; TUMOR GROWTH;

EID: 45849113190     PISSN: 15228002     EISSN: 14765586     Source Type: Journal    
DOI: 10.1593/neo.08304     Document Type: Article

References (50)

1. Scheurlen WG, Schwabe GC, Joos S, Mollenhauer J, Sorensen N, and Kuhl J (1998). Molecular analysis of childhood primitive neuroectodermal tumors defines markers associated with poor outcome. J Clin Oncol 16, 2478-2485.
2. Crawford JR, MacDonald TJ, and Packer RJ (2007). Medulloblastoma in childhood: new biological advances. Lancet Neurol 6, 1073-1085.
3. Distel L, Neubauer S, Varon R, Holter W, and Grabenbauer G (2003). Fatal toxicity following radio- and chemotherapy of medulloblastoma in a child with unrecognized Nijmegen breakage syndrome. Med Pediatr Oncol 41, 44-48.
4. Juan ME, Vinardell MP, and Planas JM (2002). The daily oral administration of high doses of transresveratrol to rats for 28 days is not harmful. J Nutr 132, 257-260.
5. Azios NG, Krishnamoorthy L, Harris M, Cubano LA, Cammer M, and Dharmawardhane SF (2007). Estrogen and resveratrol regulate Rac and Cdc42 signaling to the actin cytoskeleton of metastatic breast cancer cells. Neoplasia 9, 147-158.
6. Wang Q, Li H, Wang XW, Wu DC, Chen XY, and Liu J (2003). Resveratrol promotes differentiation and induces Fas-independent apoptosis of human medulloblastoma cells. Neurosci Lett 351, 83-86.
7. Vervoorts J, Lüscher-Firzlaff J, and Lüscher B (2006). The ins and outs of MYC regulation by posttranslational mechanisms. J Biol Chem 281, 34725-34729.
8. Stearns D, Chaudhry A, Abel TW, Burger PC, Dang CV, and Eberhart CG (2006). c-Myc overexpression causes anaplasia in medulloblastoma. Cancer Res 66, 673-681.
9. Zhang P, Li H, Wu ML, Chen XY, Kong QY, Wang XW, Sun Y, Wen S, and Liu J (2006). c-Myc downregulation: a critical molecular event in resveratrol-induced cell cycle arrest and apoptosis of human medulloblastoma cells. J Neurooncol 80, 123-131.
10. Rawlings JS, Rosler KM, and Harrison DA (2004). The JAK/STAT signaling pathway. J Cell Sci 117, 1281-1283.
11. Zhang L, Badgwell DB, Bevers JJ III, Schlessinger K, Murray PJ, Levy DE, and Watowich SS (2006). IL-6 signaling via the STAT3/SOCS3 pathway: functional analysis of the conserved STAT3 N-domain. Mol Cell Biochem 288, 179-189.
12. Buettner R, Mora LB, and Jove R (2002). Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 8, 945-954.
13. Pizem J, Cort A, Zadravec-Zaletel L, and Popovic M (2005). Survivin is a negative prognostic marker in medulloblastoma. Neuropathol Appl Neurobiol 31, 422-428.
14. Rosen DG, Mercado-Uribe I, Yang G, Bast RC, Amin HM, Lai R, and Liu J (2006). The role of constitutively active signal transducer and activator of transcription 3 in ovarian tumorigenesis and prognosis. Cancer 107, 2730-2740.
15. Schaefer LK, Ren Z, Fuller GN, and Schaefer TS (2002). Constitutive activation of Stat3a in brain tumors: localization to tumor endothelial cells and activation by the endothelial tyrosine kinase receptor (VEGFR-2). Oncogene 21, 2058-2065.
16. Lee JH, Schütte D, Wulf G, Füzesi L, Radzun HJ, Schweyer S, Engel W, and Nayernia K (2006). Stem-cell protein Piwil2 is widely expressed in tumors and inhibits apoptosis through activation of Stat3/Bcl-XL pathway. Hum Mol Genet 15, 201-211.
17. Bhardwai A, Sethi G, Vadhan-Raj S, Bueso-Ramos C, Takada Y, Gaur U, Nair AS, Shishodia S, and Aggarwal BB (2007). Resveratrol inhibits proliferation, induces apoptosis, and overcomes chemoresistance through down-regulation of STAT3 and nuclear factor-kappaB-regulated antiapoptotic and cell survival gene products in human multiple myeloma cells. Blood 109, 2293-2302.
18. Kotha A, Sekharam M, Cilenti L, Siddiquee K, Khaled A, Zervos AS, Carter B, Turkson J, and Jove R (2006). Resveratrol inhibits Src and Stat3 signaling and induces the apoptosis of malignant cells containing activated Stat3 protein. Mol Cancer Ther 5, 621-629.
19. Liu J, Li JW, Gang Y, Guo L, and Li H (1999). Expression of leukemia-inhibitory factor as an autocrinal growth factor in human medulloblastomas. J Cancer Res Clin Oncol 125, 475-480.
20. Keles GE, Berger MS, Srinivasan J, Kolstoe DD, Bobola MS, and Silber JR (1995). Establishment and characterization of four human medulloblastoma-derived cell lines. Oncol Res 7, 493-503.
21. Gibbs CP, Kukekov VG, Reith JD, Tchigrinova O, Suslov ON, Scott EW, Ghivizzani SC, Ignatova TN, and Steindler DA (2005). Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia 7, 967-976.
22. Ikeguchi M and Kaibara N (2001). Changes in survivin messenger RNA level during cisplatin treatment in gastric cancer. Int J Mol Med 8, 661-666.
23. Jung EM, Lee TJ, Park JW, Bae YS, Kim SH, Choi YH, and Kwon TK (2008). The novel phospholipase C activator, m-3M3FBS, induces apoptosis in tumor cells through caspase activation, down-regulation of XIAP and intracellular calcium signaling. Apoptosis 13, 133-145.
24. Ben-Shlomo A, Miklovsky I, Ren SG, Yong WH, Heaney AP, Culler MD, and Melmed S (2003). Leukemia inhibitory factor regulates prolactin secretion in prolactinoma and lactotroph cells. J Clin Endocrinol Metab 88, 858-863.
25. Grotzer MA, Hogarty MD, Janss AJ, Liu X, Zhao H, Eggert A, Sutton LN, Rorke LB, Brodeur GM, and Phillips PC (2001). MYC messenger RNA expression predicts survival outcome in childhood primitive neuroectodermal tumor/medulloblastoma. Clin Cancer Res 7, 2425-2433.
26. Lambert W, Agarwal R, Howe W, Clark AF, and Wordinger RJ (2001). Neurotrophin and neurotrophin receptor expression by cells of the human lamina cribrosa. Invest Ophthalmol Vis Sci 42, 2315-2323.
27. Przyborski SA, Smith S, and Wood A (2003). Transcriptional profiling of neuronal differentiation by human embryonal carcinoma stem cells in vitro. Stem Cells 21, 459-471.
28. Ghosh R, Garcia GE, Crosby K, Inoue H, Thompson IM, Troyer DA, and Kumar AP (2007). Regulation of Cox-2 by cyclic AMP response element binding protein in prostate cancer: potential role for nexrutine. Neoplasia 9, 893-899.
29. Simile MM, De Miglio MR, Muroni MR, Frau M, Asara G, Serra S, Muntoni MD, Seddaiu MA, Daino L, Feo F, et al. (2004). Down-regulation of c-myc and Cyclin D1 genes by antisense oligodeoxy nucleotides inhibits the expression of E2F1 and in vitro growth of HepG2 and Morris 5123 liver cancer cells. Carcinogenesis 25, 333-341.
30. Kartenbeck J, Schwechheimer K, Moll R, and Franke WW (1984). Attachment of vimentin filaments to desmosomal plaques in human meningiomal cells and arachnoidal tissue. J Cell Biol 98, 1072-1081.
31. Huang C, Cao J, Huang KJ, Zhang F, Jiang T, Zhu L, and Qiu ZJ (2006). Inhibition of STAT3 activity with AG490 decreases the invasion of human pancreatic cancer cells in vitro. Cancer Sci 97, 1417-1423.
32. Squarize CH, Castilho RM, Sriuranpong V, Pinto DS Jr, and Gutkind JS (2006). Molecular cross-talk between the NFkappaB and STAT3 signaling pathways in head and neck squamous cell carcinoma. Neoplasia 8, 733-746.
33. Xiong H, Zhang ZG, Tian XQ, Sun DF, Liang QC, Zhang YJ, Lu R, Chen YX, and Fang JY (2008). Inhibition of JAK1, 2/STAT3 signaling induces apoptosis, cell cycle arrest, and reduces tumor cell invasion in colorectal cancer cells. Neoplasia 10, 287-297.
34. Emery B, Merson TD, Snell C, Young KM, Ernst M, and Kilpatrick TJ (2006). SOCS3 negatively regulates LIF signaling in neural precursor cells. Mol Cell Neurosci 31, 739-747.
35. Hirabayashi Y and Gotoh Y (2005). Stage-dependent fate determination of neural precursor cells in mouse forebrain. Neurosci Res 51, 331-336.
36. Zhang SS, Liu MG, Kano A, Zhang C, Fu XY, and Barnstable CJ (2005). STAT3 activation in response to growth factors or cytokines participates in retina precursor proliferation. Exp Eye Res 81, 103-115.
37. Wada K, Nakajima A, Katayama K, Kudo C, Shibuya A, Kubota N, Terauchi Y, Tachibana M, Miyoshi H, Kamisaki Y, et al. (2006). Peroxisome proliferator-activated receptor gamma-mediated regulation of neural stem cell proliferation and differentiation. J Biol Chem 281, 12673-12681.
38. Rahaman SO, Harbor PC, Chernova O, Barnett GH, Vogelbaum MA, and Haque SJ (2002). Inhibition of constitutively active Stat3 suppresses proliferation and induces apoptosis in glioblastoma multiforme cells. Oncogene 21, 8404-8413.
39. Tsareva SA, Moriggl R, Corvinus FM, Wiederanders B, Schütz A, Kovacic B, and Friedrich K (2007). Signal transducer and activator of transcription 3 activation promotes invasive growth of colon carcinomas through matrix metalloproteinase induction. Neoplasia 9, 279-291.
40. Gu F, Hata R, Ma YJ, Tanaka J, Mitsuda N, Kumon Y, Hanakawa Y, Hashimoto K, Nakajima K, and Sakanaka M (2005). Suppression of Stat3 promotes neurogenesis in cultured neural stem cells. J Neurosci Res 81, 163-171.
41. 2 signaling pathway. J Biol Chem 281, 24831-24846.
42. Sakinah SA, Handayani ST, and Hawariah LP (2007). Zerumbone induced apoptosis in liver cancer cells via modulation of Bax/Bcl-2 ratio. Cancer Cell Int 7, 4.
43. Olivetti G, Abbi R, Quaini F, Kajstura J, Cheng W, Nitahara JA, Quaini E, Di Loreto C, Beltrami CA, Krajewski S, et al. (1997). Apoptosis in the failing human heart. N Engl J Med 336, 1131-1141.
44. Moorjani N, Catarino P, Trabzuni D, Saleh S, Moorji A, Dzimiri N, Al-Mohanna F, Westaby S, and Ahmad M (2007). Upregulation of Bcl-2 proteins during the transition to pressure overload-induced heart failure. Int J Cardiol 116, 27-33.
45. Ramalho RM, Cortez-Pinto H, Castro RE, Solá S, Costa A, Moura MC, Camilo ME, and Rodrigues CM (2006). Apoptosis and Bcl-2 expression in the livers of patients with steatohepatitis. Eur J Gastroenterol Hepatol 18, 21-29.
46. Su Y, Zhang X, and Sinko PJ (2007). Exploitation of drug-induced Bcl-2 overexpression for restoring normal apoptosis function: a promising new approach to the treatment of multidrug resistant cancer. Cancer Lett 253, 115-123.
47. Ban JO, Yuk DY, Woo KS, Kim TM, Lee US, Jeong HS, Kim DJ, Chung YB, Hwang BY, Oh KW, et al. (2007). Inhibition of cell growth and induction of apoptosis via inactivation of NF-kappaB by a sulfur compound isolated from garlic in human colon cancer cells. J Pharmacol Sci 104, 374-383.
48. Fuentealba RA, Farias G, Scheu J, Bronfman M, Marzolo MP, and Inestrosa NC (2004). Signal transduction during amyloid-beta-peptide neurotoxicity: role in Alzheimer disease. Brain Res Brain Res Rev 47, 275-289.
49. Snyder M, Huang XY, and Zhang JJ (2008). Identification of novel direct STAT3 target genes for control of growth and differentiation. J Biol Chem 283, 3791-3798.
50. Moon C, Yoo JY, Matarazzo V, Sung YK, Kim EJ, and Ronnett GV (2002). Leukemia inhibitory factor inhibits neuronal terminal differentiation through STAT3 activation. Proc Natl Acad Sci USA 99, 9015-9020.